Literature DB >> 28861662

Extracellular Expression in Aspergillus niger of an Antibody Fused to Leishmania sp. Antigens.

Denis Magaña-Ortíz1, Francisco Fernández2, Achim M Loske3, Miguel A Gómez-Lim4.   

Abstract

Nucleoside hydrolase and sterol 24-c-methyltransferase, two antigenic proteins of Leishmania sp., were expressed in Aspergillus niger. Genetic transformation of conidia was achieved using underwater shock waves. scFv antibody addressed to DEC205, a receptor of dendritic cells, was fused to two proteins of Leishmania sp. Receptor 205 has a relevant role in the immune system in mammals; it can modulate T cell response to different antigens. Extracellular expression strategy of recombinant antibody was achieved using a fragment of native glucoamylase A (514 aa) as a carrier. Fermentations in shake flasks showed that the recombinant protein (104 kDa) was expressed and secreted only when maltose was used as carbon source; on the contrary, the expression was highly repressed in presence of xylose. Noteworthy, recombinant protein was secreted without glucoamylase-carrier and accumulation at intracellular level was not observed. The results presented here demonstrate the high value of Aspergillus niger as biotechnological platform for recombinant antibodies against Leishmania sp. at low cost. To the best of our knowledge, this is the first report about the recombinant expression of antigenic proteins of Leishmania sp. in filamentous fungi. The protein obtained can be used to explore novel strategies to induce immunity against Leishmania sp. or it can be employed in diagnostic kits to detect this neglected disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28861662     DOI: 10.1007/s00284-017-1348-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  24 in total

Review 1.  Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.

Authors:  Christian R Engwerda; Manabu Ato; Paul M Kaye
Journal:  Trends Parasitol       Date:  2004-11

2.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Authors:  Yasuyuki Goto; Lisa Y Bogatzki; Sylvie Bertholet; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2007-08-20       Impact factor: 3.641

Review 3.  Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms.

Authors:  L G Frenken; J G Hessing; C A Van den Hondel; C T Verrips
Journal:  Res Immunol       Date:  1998 Jul-Aug

Review 4.  Efficient production of secreted proteins by Aspergillus: progress, limitations and prospects.

Authors:  R J Gouka; P J Punt; C A van den Hondel
Journal:  Appl Microbiol Biotechnol       Date:  1997-01       Impact factor: 4.813

5.  Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori.

Authors:  Vivi Joosten; Robin J Gouka; Cees A M J J van den Hondel; C Theo Verrips; B Christien Lokman
Journal:  Appl Microbiol Biotechnol       Date:  2004-09-17       Impact factor: 4.813

6.  Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis.

Authors:  P Tsagozis; E Karagouni; E Dotsika
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

Review 7.  Innate immunity against Leishmania infections.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Microbiol       Date:  2015-08-11       Impact factor: 3.715

8.  Evaluation of Aspergillus niger as host for virus-like particle production, using the hepatitis B surface antigen as a model.

Authors:  Annette Plüddemann; Willem H Van Zyl
Journal:  Curr Genet       Date:  2003-06-11       Impact factor: 3.886

9.  Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.

Authors:  Ines Matos; Olga Mizenina; Ashira Lubkin; Ralph M Steinman; Juliana Idoyaga
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

10.  Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.

Authors:  Malcolm S Duthie; Michelle Favila; Kimberley A Hofmeyer; Yeung L Tutterrow; Steven J Reed; John D Laurance; Alessandro Picone; Jeffrey Guderian; H Remy Bailor; Aarthy C Vallur; Hong Liang; Raodoh Mohamath; Julie Vergara; Randall F Howard; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2016-05-01       Impact factor: 3.641

View more
  6 in total

1.  Recombinant Protein Production and Purification of Insoluble Proteins.

Authors:  Neus Ferrer-Miralles; Paolo Saccardo; José Luis Corchero; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

2.  Mammalian Cell Culture as a Platform for Veterinary Vaccines.

Authors:  Thailín Lao González; Ileanet Ávalos Olivera; Alina Rodríguez-Mallon
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review.

Authors:  Arun K Dangi; Rajeshwari Sinha; Shailja Dwivedi; Sanjeev K Gupta; Pratyoosh Shukla
Journal:  Front Pharmacol       Date:  2018-06-12       Impact factor: 5.810

4.  Constructing a novel expression system by specific activation of amylase expression pathway in Penicillium.

Authors:  Changyu Pi; Zhe Zhang; Boyu Xiang; Hongwei Tian; Qinzhen Liao; Yu Chen; Liqiu Xia; Yibo Hu; Shengbiao Hu
Journal:  Microb Cell Fact       Date:  2020-07-29       Impact factor: 5.328

Review 5.  A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals.

Authors:  B Owczarek; A Gerszberg; K Hnatuszko-Konka
Journal:  Biomed Res Int       Date:  2019-01-08       Impact factor: 3.411

Review 6.  Inducible promoters and functional genomic approaches for the genetic engineering of filamentous fungi.

Authors:  Janina Kluge; Dominik Terfehr; Ulrich Kück
Journal:  Appl Microbiol Biotechnol       Date:  2018-06-02       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.